Who owns PROCESSA PHARMACEUTICALS INC?
- Ticker: PCSA
- CUSIP Number: 74275c304
Tip: Access positions for across all investors
Analyze quarterly positions in Processa Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Processa Pharmaceuticals stock
Who bought or sold PROCESSA PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 24k | $55k | 0% | Jun 2024 |
|
| Geode Capital Management | 20k | $27k | 14% | Sep 2024 |
|
| Tower Research Capital | 3.0k | $6.7k | -33% | Jun 2024 |
|
| Wells Fargo & Company | 154.00 | $210.995400 | 0% | Sep 2024 |
|
| Hanson McClain Advisors | 85.00 | $117.002500 | 0% | Sep 2024 |
|
| Bank of America Corporation | 24.00 | $33.000000 | 14% | Sep 2024 |
|
| Absolute Investment Management | 1.00 | $2.000000 | 0% | Sep 2024 |
|
Who sold out of Processa Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Two Sigma Investments | Mar 2024 | 24k | $57k |
| Main Street Group | Jun 2024 | 100.00 | $209.000000 |
| Royal Bank of Canada | Jun 2024 | 4.00 | $0 |